Renaissance Technologies
SRTA

Renaissance Technologies’s Strata Critical Medical Inc SRTA Stock Holding History

Renaissance Technologies’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Buy
492,386
+17,500
+4% +$92.1K ﹤0.01% 1823
2026
Q1 		$1.99M Sell
474,886
-123,900
-21% -$596K ﹤0.01% 1900
2025
Q4 		$2.88M Buy
598,786
+400
+0.1% +$1.94K ﹤0.01% 1649
2025
Q3 		$3.03M Sell
598,386
-113,300
-16% -$501K ﹤0.01% 1787
2025
Q2 		$2.87M Buy
711,686
+121,647
+21% +$396K ﹤0.01% 1882
2025
Q1 		$1.61M Buy
590,039
+206,853
+54% +$742K ﹤0.01% 2131
2024
Q4 		$1.63M Buy
383,186
+85,486
+29% +$325K ﹤0.01% 2182
2024
Q3 		$875K Buy
297,700
+6,400
+2% +$20.4K ﹤0.01% 2526
2024
Q2 		$1.01M Buy
291,300
+46,600
+19% +$155K ﹤0.01% 2307
2024
Q1 		$697K Buy
244,700
+49,300
+25% +$152K ﹤0.01% 2703
2023
Q4 		$690K Sell
195,400
-194,799
-50% -$559K ﹤0.01% 2609
2023
Q3 		$1.01M Buy
390,199
+182,699
+88% +$642K ﹤0.01% 2286
2023
Q2 		$818K Buy
207,500
+61,400
+42% +$195K ﹤0.01% 2587
2023
Q1 		$494K Buy
146,100
+44,717
+44% +$182K ﹤0.01% 2897
2022
Q4 		$363K Buy
101,383
+53,783
+113% +$230K ﹤0.01% 3132
2022
Q3 		$192K Buy
47,600
+26,000
+120% +$134K ﹤0.01% 3398
2022
Q2 		$96K Buy
+21,600
New +$156K ﹤0.01% 3862

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies's SRTA Position: Q2 2026 in Review

Renaissance Technologies increased its Strata Critical Medical Inc (SRTA) stake by 3.7% in Q2 2026, buying an estimated $92.1K and bringing the position to 492,386 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1823.

Renaissance Technologies first reported a position in SRTA in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.03M in Q3 2025. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Renaissance Technologies held 492,386 shares of Strata Critical Medical Inc worth $2.59M as of Q2 2026.
  • Renaissance Technologies bought 17,500 Strata Critical Medical Inc shares in Q2 2026, an estimated $92.1K.
  • Strata Critical Medical Inc made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1823 holding.
  • Renaissance Technologies first reported a position in Strata Critical Medical Inc in Q2 2022 and has held it in 17 quarters since.
  • Renaissance Technologies's Strata Critical Medical Inc position peaked at $3.03M in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.